BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1186495)

  • 1. Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma--an effect apparently not mediated by gastrin.
    Wells SA; Cooper CW; Ontjes DA
    Metabolism; 1975 Nov; 24(11):1215-9. PubMed ID: 1186495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid.
    Hennessy JF; Gray TK; Cooper CW; Ontjes DA
    J Clin Endocrinol Metab; 1973 Jan; 36(1):200-3. PubMed ID: 4681885
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
    Starling JR; Harris C; Granner DK
    Arch Surg; 1978 Mar; 113(3):241-3. PubMed ID: 637688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of calcitonin and gastrin in rats with transplanted medullary thyroid carcinoma.
    Normann T; Normann E; Schrumpf E; Gautvik KM
    Acta Pathol Microbiol Scand A; 1977 Jan; 85A(1):63-72. PubMed ID: 835355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
    Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
    Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrocalcitonin: stimulation of secretion by pentagastrin.
    Cooper CW; Schwesinger WH; Mahgoub AM; Ontjes DA
    Science; 1971 Jun; 172(3989):1238-40. PubMed ID: 5576157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
    Ahuja S
    Acta Endocrinol (Copenh); 1990 May; 122(5):640-2. PubMed ID: 2112816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
    Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
    Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
    Emmertsen K; Nielsen HE; Mosekilde L; Hansen HH
    Acta Med Scand; 1980; 207(5):367-9. PubMed ID: 7386230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary carcinoma and thyrocalcitonin.
    Tubiana M; Milhaud G; Coutris G; Lacour J; Parmentier C; Bok B
    Br Med J; 1968 Oct; 4(5623):87-9. PubMed ID: 5748583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
    Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
    J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II.
    Wells SA; Ontjes DA; Cooper CW; Hennessy JF; Ellis GJ; McPherson HT; Sabiston DC
    Ann Surg; 1975 Oct; 182(4):362-70. PubMed ID: 1180576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine and calcitonin release from medullary thyroid carcinoma.
    Farndon JR; Lewis KR; Dale JK; Hinshaw WM; Dilley WG; Wells SA
    Cancer; 1983 Apr; 51(7):1221-5. PubMed ID: 6130834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: dynamic studies with calcium, pentagastrin and somatostatin.
    Bertagna XY; Bloomgarden ZT; Rabin D; Roberts LJ; Orth DN
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):115-23. PubMed ID: 6108170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of elevated gastrin levels on calcitonin secretion.
    Erdogan MF; Gursoy A; Kulaksizoglu M
    J Endocrinol Invest; 2006 Oct; 29(9):771-5. PubMed ID: 17114906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of clinical and physiological relationship between gastrin and calcitonin in man.
    Heynen G; Brassine A; Daubresse JC; Ligny G; Kanis JA; Gaspar S; Franchimont P
    Eur J Clin Invest; 1981 Aug; 11(4):331-5. PubMed ID: 6795050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whisky: a new provacative test for calcitonin secretion.
    Dymling JF; Ljungberg O; Hillyard CJ; Greenberg PB; Evans IM; MacIntyre I
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):500-9. PubMed ID: 947123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man.
    Owyang C; Heath H; Sizemore GW; Go VL
    Am J Dig Dis; 1978 Dec; 23(12):1084-8. PubMed ID: 367153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.